The Future of Value-Based Care and Implications for US Healthcare

Moderator:

Faculty:

Digital Healthcare Technology: A Robust Growth Sector

Moderator:

Faculty:

Warranties and Reinsurance to Manage Risk: Pharma and Provider Solutions

Moderator:

Faculty:

End of Life: Have We Made Improvements to this Legacy Issue?

Moderator:

Faculty:

IRA Impact: Pharma Translating Impact Over the Next 5 Years

Moderator:

Faculty:

Cell and Gene Therapy Access – Product Cycle, CMS Model, and Patient Support

Moderator:

Faculty:

Revenue Cycle Policy and Trends

Moderator:

Faculty:

How ePRO Technology Benefit Cancer Patients

Moderator:

Faculty:

IRA Healthcare Industry: Translating Impact Over the Next 5 Years

Moderator:

Faculty:

Value-Based Agreements in Oncology: What Cancer Care Practices are Doing in the Marketplace Today

Moderator:

Faculty:

Cell and Gene Therapy and the Future Impact on Cancer Care

Moderator:

Faculty:

Oncology Drug Shortages

Moderator:

Faculty:

IRA Providers: Translating Impact Over the Next 5 Years

Moderator:

Faculty:

Disparities and the Impact on Cancer Care

Moderator:

Faculty:

Generative AI, Large Language Models in Personalized Medicine

Moderator:

Faculty:

Understanding the Economics of the Oncology Drug Pricing Ecosystem

Moderator:

Faculty:

Improving the Collaboration Between Oncology Practices and the PBM Industry

Moderator:

Faculty:

Integrating Precision Medicine Data into Real-World Pathways and Clinical Utility

Moderator:

Faculty:

Succeeding in Value-Based Payment Arrangements: ASCO’s Patient Centered Cancer Care Certification Pilot

Moderator:

Faculty:

Oncology and Vertically Integrated Supply Channels

Moderator:

Faculty:

Pharma’s Role and Participation in Value-Based Agreements

Moderator:

Faculty:

Challenges in Transitioning to Value-Based Care

Moderator:

Faculty:

GPOs and Their Future Impact and Role

Moderator:

Faculty:

Examining the Clinical, Quality and Cost Impact of Breaking Down Silos Between Medical & Pharmacy Care

Moderator:

Faculty:

Enhancing Oncology Model (EOM) Update

Moderator:

Faculty:

Innovative Reimbursement Models Based on Outcomes and Services

Moderator:

Faculty:

Pharma Value-Based Programs: What Worked, Failed and is the Future

Moderator:

Faculty:

340B Programs: Current State

Moderator:

Faculty:

EOM: Understanding Why Providers Did Not Sign on to the CMS Program

Moderator:

Faculty:

Employers and the Impact on Cancer Care

Moderator:

Faculty:

Personalized Medicine Cancer Therapy Management

Moderator:

Faculty:

The Economic Realities of Cancer Site of Care

Moderator:

Faculty:

Align & Thrive: Matching Information Exchange with Financial Flows

Moderator:

Faculty:

Disruptive Innovation: Can the Healthcare System Transform from Within?

Moderator:

Faculty:

Beyond EOM: How does Health Equity Fit in Multi-Stakeholder Value-Based Care Partnership

Moderator:

Faculty:

Future Models of Precision Medicine

Moderator:

Faculty:

Building the Conglomerates of Oncology Practice: Consolidation, Competition, and Care

Moderator:

Faculty:

Oncology Pipeline Report

Moderator:

Faculty:

Cancer Moonshot Update

Moderator:

Faculty:

Payers Practicing Medicine? Medical Necessity, Prior Authorization, Patient Records, and More, Oh My!

Moderator:

Faculty:

Observations and Trends in Cancer Care

Moderator:

Faculty:

Artificial Intelligence and the Impact on Care Delivery Outcomes

Moderator:

Faculty:

Evolution of Clinical Trials

Moderator:

Faculty:

Using Voice of Patient Data to Measure Inequities and Address Health Disparities

Moderator:

Faculty:

The Battle for Oncology Margin in US Drug Channels

Moderator:

Faculty:

Establishing Value for Pharmaceuticals

Moderator:

Faculty:

Cancer Vaccines a New Treatment Paradigm

Moderator:

Faculty:

The Evolution of Patient Advocacy

Moderator:

Faculty:

The Ever-Changing Relationships Between Regional and Community in Cancer Care

Moderator:

Faculty:

Transforming the Oncology Practice Clinically and Financially

Moderator:

Faculty:

Precision Medicine’s Role Ensuring Accurate Diagnosis and Treatment

Moderator:

Faculty:

The Evolution of the MIP and Influences Impacting Patient Care

Moderator:

Faculty:

Payers and Future Value-Based Transformation

Moderator:

Faculty:

A View on Legislation and Policy Out of Washington Ahead

Moderator:

Faculty:

Value-Based Agreements: Roadmap from Strategy to Design Through Implementation

Moderator:

Faculty:

The Essential to Achieving Success in Value-Based Care: Medically Integrated Pharmacies & Dispensaries

Moderator:

Faculty:

IRA and the Regulator’s Role in Price Negotiations

Moderator:

Faculty:

Harmonizing Legal and Regulatory Issues with Value-Based Agreements

Moderator:

Faculty:

Healthcare Interoperability: Advancing the Data State of Play in Value-Based Oncology Care

Moderator:

Faculty:

Biosimilars and Industry Observations: Future Sustainability

Moderator:

Faculty:

Creating Collaborative Partnerships: Stakeholder Perspectives Between Pharma, Payers, and Providers

Moderator:

Faculty:

Unified Leadership Efforts to Address and Shape the Future of Cancer Care

Moderator:

Faculty:

New Patient-Centric Cancer Care Models

Moderator:

Faculty:

What We Can Learn from the Pediatric Cancer Experience

Moderator:

Faculty:

Good and Bad: Washington and State Policy and Economics Impacting Healthcare

Moderator:

Faculty:

Capital Markets View on Pharmaceutical Innovation and Value

Moderator:

Faculty:

Navigating Payer Complexities in Oncology Coverage, Impact of Value Contracting & Ensuring Providers Understand Patient Access Implications

Moderator:

Faculty:

Transparent PBM Models

Moderator:

Faculty:

PBMs Facing Investigations and Potential Legislative Impact

Moderator:

Faculty:

Practice Transformation Through Value-Based Analytics

Moderator:

Faculty:

Financial Toxicity

Moderator:

Faculty:

The Impact of Inflation on the Healthcare Ecosystem

Moderator:

Faculty:

Primary Care Risk-Sharing Agreements with Specialty Cancer Care

Moderator:

Faculty:

Unlocking Innovation in Value-Based Care: Reflections on Current Policy Efforts Surrounding PBMs & Where Regulators Should Focus Next

Moderator:

Faculty:

Specialty Oncology Pharmacy Networks

Moderator:

Faculty:

A Holistic Overview on the Real Cost of Cancer on Patients

Moderator:

Faculty:

Clinician Leadership Role in Transforming Cancer Care

Moderator:

Faculty:

AI and ML Decision Support Models

Moderator:

Faculty:

Surgical Oncology and the Impact and Role in Value-Based Agreements

Moderator:

Faculty:

Proactive Financial Assistance

Moderator:

Faculty:

Rise of MA Health Plan and Impact on Cancer Care

Moderator:

Faculty:

Payer/Provider Collaboration – What Will the Future Hold?

Moderator:

Faculty:

How Do I Handle Bundle Payments

Moderator:

Faculty:

Radiation Oncology: A New Approach and Model

Moderator:

Faculty:

A Case for Sustaining Navigation the Economic Value and Metrics Behind Improving Outcomes and Quality of Life

Moderator:

Faculty:

Addressing the Uncertainty of Cell and Gene Therapy’s Durability of Response through Novel Financing Arrangements

Moderator:

Faculty:

Personalized Proof - How Will the Oncology Field Accelerate Tailored Medicine Development AND Still Generate the Best Evidence?

Moderator:

Faculty:

Drug/Biologic Development; To Market; To Out-License; To be Acquired

Moderator:

Faculty:

The Rise of Concierge Benefit Managers and Impact on Cancer Care

Moderator:

Faculty:

The Voice and Rights of a Patient with Cancer

Moderator:

Faculty:

Addressing Burnout in the Oncology Industry

Moderator:

Faculty:

Radiation Oncology: Under Clinical Pathways, Transparency, and with Risk Share

Moderator:

Faculty: